STANOZOL tablets have active substance stanozolol. It stimulates anabolic processes and suppresses catabolic effects caused by glucocorticoids. This leads to an increase in muscle mass, an improvement in blood production and connective tissue, a decrease in body fat levels. The androgenic effect is moderate and may contribute to the development of male secondary sexual signs.
STANOZOL can be used during therapy in pathologies accompanied by protein synthesis disorders, injuries, burns, pre- and postoperative infections, muscular dystrophy, osteoporosis, renal failure, negative nitrogen balance in corticosteroid therapy, hypo- and aplastic anemia, as an auxiliary substance in the treatment of tuberculosis, hepatitis, and asthma.
Keep away from light. Store at a temperature below 25 °C.
No special storage conditions are required.
Do not use STANOZOL after the expiry date which is stated on the cardboard after EXP.
The expiration date refers to the last day of that month.